(en) Karikó K, Buckstein M, Ni H, Weissman D. (2005). Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA. Immunity23 (2): 165–175. PMID16111635. DOI: 10.1016/j.immuni.2005.06.008.
(2010). Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Research38 (17): 5884–92. PMID20457754. PMC2943593. DOI: 10.1093/nar/gkq347.
(2008). Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Molecular Therapy16 (11): 1833–40. PMID18797453. PMC2775451. DOI: 10.1038/mt.2008.200.
nih.gov
ncbi.nlm.nih.gov
(en) Karikó K, Buckstein M, Ni H, Weissman D. (2005). Suppression of RNA Recognition by Toll-like Receptors: The Impact of Nucleoside Modification and the Evolutionary Origin of RNA. Immunity23 (2): 165–175. PMID16111635. DOI: 10.1016/j.immuni.2005.06.008.
(2010). Incorporation of pseudouridine into mRNA enhances translation by diminishing PKR activation. Nucleic Acids Research38 (17): 5884–92. PMID20457754. PMC2943593. DOI: 10.1093/nar/gkq347.
(2008). Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Molecular Therapy16 (11): 1833–40. PMID18797453. PMC2775451. DOI: 10.1038/mt.2008.200.
